Holen Sie sich die Stockscreener-App
51.95
0.04%
0.02
Schlusskurs vom Vortag:
$51.93
Offen:
$51.99
24-Stunden-Volumen:
267.19K
Relative Volume:
0.64
Marktkapitalisierung:
$2.57B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-32.22
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-2.50%
1M Leistung:
+3.20%
6M Leistung:
+8.27%
1J Leistung:
+31.55%
1-Tages-Spanne:
$51.08
$52.75
1-Wochen-Bereich:
$51.08
$53.59
52-Wochen-Spanne:
$36.20
$54.78
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Firmenname
Mirum Pharmaceuticals Inc
Sektor
Branche
Telefon
650-667-4085
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Vergleichen Sie MIRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
51.95 | 2.64B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-04-17 | Eingeleitet | Stifel | Buy |
| 2023-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-17 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-09-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2021-09-20 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-25 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-12 | Eingeleitet | Citigroup | Buy |
| 2019-08-12 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-12 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten
Mirum Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
What drives Mirum Pharmaceuticals Inc. stock priceTremendous financial leverage - Autocar Professional
What analysts say about Mirum Pharmaceuticals Inc. stockUnmatched market gains - Autocar Professional
Purpose, not just product: What sets Mirum apart - Endpoints News
Bank of New York Mellon Corp Acquires 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN
Is Mirum Pharmaceuticals Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
Mirum Pharma’s Rare Disease Bets Are Paying Off For Investors - Finimize
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Teacher Retirement System of Texas Sells 925 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Advances Phase 3 Study on Maralixibat for Cholestatic Pruritus - TipRanks
When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com
How Mirum Pharmaceuticals Inc. stock performs during market volatilityEntry Level Low Risk Picks - Newser
What makes Mirum Pharmaceuticals Inc. stock price move sharplyFree Access to Investment Community - Newser
Why Mirum Pharmaceuticals Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser
Mirum Pharmaceuticals stock hits all-time high at $54.46 - Investing.com Australia
Mirum Hits All-Time HighIs There More Upside Ahead? - RTTNews
Mirum Pharmaceuticals stock hits all-time high at $54.46 By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals price target raised to $76 from $68 at Evercore ISI - MSN
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KBC Group NV Makes New Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Top Analyst Ratings From Last Week - The Globe and Mail
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Is Breakeven Near? - 富途牛牛
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen - Defense World
Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria
Wealth Enhancement Advisory Services LLC Purchases 339 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Insiders Sold US$2.2m Of Shares Suggesting Hesitancy - simplywall.st
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell 3000E Index - MarketScreener
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell Microcap Index - MarketScreener
When (MIRM) Moves Investors should Listen - news.stocktradersdaily.com
Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Where are the Opportunities in (MIRM) - news.stocktradersdaily.com
Insider Sell: William Fairey Sells Shares of Mirum Pharmaceutica - GuruFocus
High Growth Tech Stocks In The US Market - Yahoo Finance
Cantor Fitzgerald Predicts MIRM FY2026 Earnings - Defense World
Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.06 Million Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com India
Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus
Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com Australia
Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharmaceuticals Inc (MIRM) - GuruFocus
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):